111 Inc 's Revenue in the fiscal year 2025 $ 1,795.49 millions
111 Inc 's Revenue in the fiscal year 2024 $ 1,972.96 millions
111 Inc 's Revenue in the fiscal year 2023 $ 2,105.40 millions
111 Inc 's Revenue in the fiscal year 2022 $ 1,959.74 millions
111 Inc 's Revenue in the fiscal year 2021 $ 1,949.90 millions
YI Revenue fourth quarter 2025 Y/Y Growth Comment
111 Inc reported decrease in Revenue in the fourth quarter 2025 by -9% to $ 1,795.49 millions, from the same quarter in 2024. The decrease in the fourth quarter 2025 111 Inc 's Revenue compares unfavorably to the Company's average Revenue increase of 14.19%.
Looking into fourth quarter 2025 results within Pharmacy Services & Retail Drugstore industry 5 other companies have achieved higher Revenue growth. While 111 Inc ' s Revenue decline of -9% ranks overall at the positon no. 2174 in the fourth quarter 2025.
111 Inc 's cumulative 12 months Revenue continue to decline, but on the faster rate at -9% year on year, at Dec 31 2025 compare to the -6.29% decrease at Dec 31 2024. If the 111 Inc 's fiscal year would end at Dec 31 2025, annual Revenue would be $1,795 millions.
Among companies within the Retail sector 5 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 403, from total ranking in previous quarter at 2156.
111 Inc 's cumulative 12 months Revenue continue to decline, but on the faster rate at -9% year on year, at Dec 31 2025 compare to the -6.29% decrease at Dec 31 2024. If the 111 Inc 's fiscal year would end at Dec 31 2025, annual Revenue would be $1,795 millions.
Among companies within the Retail sector 5 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 403, from total ranking in previous quarter at 2156.
About 111 Inc Revenue Growth Rates (YI), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.